Compounds > n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid
Page last updated: 2024-08-24

n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Cardiomyopathies

n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid has been researched along with Cardiomyopathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, AH; Dweck, MR; Newby, DE; Semple, SIK; Spath, NB; Thompson, G1

Reviews

1 review(s) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Cardiomyopathies

ArticleYear
Manganese-enhanced MRI of the myocardium.
    Heart (British Cardiac Society), 2019, Volume: 105, Issue:22

    Topics: Animals; Calcium Signaling; Cardiomyopathies; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Manganese; Myocardium; Predictive Value of Tests; Prognosis; Pyridoxal Phosphate; Tissue Survival

2019